Arginase Inhibition in Humans With Obesity
NCT05536934
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Obese
Endothelial Function
Interventions
DRUG:
Nω-hydroxy-nor-arginine
Sponsor
Karolinska Institutet